Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
- Conditions
- Interventions
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 480
- Registration Number
- NCT06723080
- Locations
- 🇨🇳
Chinese Academy of Medical Sciences Hospital for Skin Diseases, Nanjing, Jiangsu, China
Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors
- First Posted Date
- 2024-10-26
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 54
- Registration Number
- NCT06658353
- Locations
- 🇨🇳
Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects
- Conditions
- Interventions
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 56
- Registration Number
- NCT06619951
- Locations
- 🇨🇳
Zhongda Hospital,Affiliated to Southeast University, Nanjing, Jiangsu, China
Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
- Conditions
- Interventions
- First Posted Date
- 2024-08-29
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 1000
- Registration Number
- NCT06577519
- Locations
- 🇨🇳
General Hospital of Northern Theater Command of Chinese PLA, Shenyang, Liaoning, China
Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects
- First Posted Date
- 2024-07-31
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 84
- Registration Number
- NCT06529445
- Locations
- 🇨🇳
Zhongda Hospital,Affiliated to Southeast University, Nanjing, Jiangsu, China
Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis
- First Posted Date
- 2023-08-24
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 80
- Registration Number
- NCT06009094
- Locations
- 🇨🇳
Chinese Academy of Medical Sciences Hospital of Skin Disease, Nanjing, Jiangsu, China
Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
- Conditions
- Interventions
- First Posted Date
- 2023-08-18
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 149
- Registration Number
- NCT05997927
- Locations
- 🇨🇳
Chinese Academy of Medical Sciences Hospital for Skin Diseases, Nanjing, Jiangsu, China
A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.
- Conditions
- Interventions
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 30
- Registration Number
- NCT05874622
- Locations
- 🇨🇳
The First Bethune Hospital of Jilin University, Changchun, Jilin, China
Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
- Conditions
- Interventions
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 180
- Registration Number
- NCT05814939
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Assessment of the Effect of Omeprazole on Vicagrel in Healthy Subjects
- First Posted Date
- 2022-12-14
- Last Posted Date
- 2023-01-31
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 20
- Registration Number
- NCT05651074
- Locations
- 🇨🇳
Phase I Clinical Research Center of The First Hospital of Jilin University, Chang chun, Jilin, China